Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Confounded pathways
BPC-157 and Thymosin Beta-4 have complementary but mechanistically distinct profiles in the published literature
The study had no placebo group, no randomisation, no blinding, no imaging-confirmed repair endpoint and no clear analytical confirmation that the second peptide was the defined TB-500 fragment
Potential risks and contraindications Given the limited understanding of DSIPs mechanisms and effects in humans, certain risks and contraindications must be taken into consideration: Unknown long-term effects : The long-term safety of DSIP has not been well-established, and the potential risks associated with chronic use remain unclear
US$ 29.61
US$ 21.23
US$ 24.75
US$ 20.14
